Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of water-soluble fullerene structure to preparation of medicine for treating Parkinson's disease

A fullerene structure, Parkinson's disease technology, applied in the field of medicine, can solve the problem of no good treatment for PD

Active Publication Date: 2020-06-23
INST OF CHEM CHINESE ACAD OF SCI +1
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, there is no good treatment for PD

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of water-soluble fullerene structure to preparation of medicine for treating Parkinson's disease
  • Application of water-soluble fullerene structure to preparation of medicine for treating Parkinson's disease
  • Application of water-soluble fullerene structure to preparation of medicine for treating Parkinson's disease

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0062] Embodiment 1, water-soluble modified hollow fullerene C 70 Preparation of -OH

[0063] (a) Add 7mL of 30% aqueous hydrogen peroxide and 3mL of 40% sodium hydroxide solution into a 100mL round bottom flask by mass, add 200mg of fullerene C 70 Solid, then add a magnetic stirrer, use a magnetic stirrer to stir at a temperature of 50°C and a speed of 1000r / min for 24h, use a solvent filter (volume: 1L, filter membrane pore size: 200nm, Jinteng Company) to filter to obtain a brownish yellow color solution.

[0064] (b) Add the solution obtained in step (a) into a 50ml centrifuge tube, and then add excess ethanol with a concentration of 95%. After centrifuging at a speed of 10000r / min for 4min, the colorless solution in the upper layer was removed, and the collected precipitate was dissolved in ultrapure water to obtain a yellow clear solution.

[0065] (c) Put the solution obtained in step (b) into a dialysis bag with a molecular weight cut-off of 3500, put it into ultrap...

Embodiment 2

[0069] Embodiment 2, fullerene C 70 -OH free radical scavenging ability test

[0070] The present invention detects water-soluble modified hollow fullerene C by electron spin resonance spectroscopy (ESR) 70 The ability of -OH to scavenge free radicals.

[0071] Detection method: UV-induced generation of hydroxyl radicals, 50 μL of 39% hydrogen peroxide, 50 μL of PBS buffer solution (PH=7.4) and a small amount (0.133 mM) of lutidine N-oxide (DMPO, free base capture agent) solution mixed, the control group was directly irradiated with ultraviolet light, while the experimental group was immediately added 20 μL of C 70 -OH, irradiated with 280nm ultraviolet light for 4min, and detected the free radical signal. like image 3 Shown, the dotted line is not adding the obtained C of Example 1 70 The blank control of -OH, the non-dotted line is the addition of C 70 -OH samples, compared with the blank control, adding C 70 The signal of the -OH sample was significantly reduced, in...

Embodiment 3

[0072] Embodiment 3, animal experiments

[0073] (1) Establishment and treatment of Parkinson's disease model

[0074] The present invention adopts the mature MPTP (1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridinehydrochloride)-induced Parkinson's disease model in mice. Studies have found that C57BL / 6 mice are the most sensitive to MPTP, so the present invention uses C57BL / 6 mice for experiments.

[0075] In the present invention, 30 C57BL / 6 mice, 10 weeks old and weighing 18-22 g, were randomly divided into control group A, model group B and treatment group C, with 10 mice in each group.

[0076] 20 mice in two groups B and C were subcutaneously injected with MPTP to establish a model, and the injection amount of MPTP was 25 mg / kg, injected once a day for 5 consecutive days. The mice in groups B and C showed resting tremor and reduced movement. Vertical tail, vertical hair, etc., prove that the model is built successfully. Treatment started on day 6 and continued until day 14....

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an application of a water-soluble fullerene structure to preparation of a medicine for treating Parkinson's disease. The water-soluble fullerene structure is high in biocompatibility, safe, free of toxic and side effects, remarkable in effect of treating Parkinson's disease, and capable of generating continuous action. The water-soluble fullerene structure disclosed by theinvention can improve tremor, slow action, poor automatic capability and the like caused by Parkinson's disease in a relatively short time; the content of dopamine in the midbrain and the corpus striatum can be increased; the mitochondrial function of the midbrain dopamine neuron can be improved; and the function of tyrosine hydroxylase can be improved.

Description

technical field [0001] The invention relates to the field of medicine, in particular to the application of a water-soluble fullerene structure in the preparation of medicines for treating Parkinson's disease. Background technique [0002] Parkinson's disease (Parkinson's disease, PD) is a common degenerative disease of the central nervous system, which mostly occurs among the elderly. According to the survey, the incidence rate of Parkinson's disease is as high as 1-2% in people over 65 years old. PD is mainly caused by a significant decrease in striatal dopamine content caused by the degeneration and death of dopaminergic neurons in the substantia nigra of the midbrain. Its clinical manifestations mainly include resting tremor, bradykinesia, muscle rigidity, and posture and gait disturbance. With the development of population aging, the research of Parkinson's disease has gradually attracted people's attention, but the cause of PD is still unclear. Aging, genetic factors, ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K33/44A61K47/54A61P25/16
CPCA61K33/44A61K47/54A61P25/16
Inventor 王春儒甄明明李雪白春礼
Owner INST OF CHEM CHINESE ACAD OF SCI